Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $6.41B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 6.60M
Average 7.51M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$24.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +41.6% | +22.7% (5yr)4 analysts |
| Net Income | N/A | N/A | N/A | N/A4 analysts |
| EBIT | N/A | N/A | N/A | N/A4 analysts |
Analysis
Recent growth has been strongest in Revenue at +41.6% over three years. Forward estimates point to Revenue at +22.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
CVS Health Corporation NYSE:CVS | $114.32B | $89.35 | Undervalued | 42.8 | +5.37% |
Elevance Health Inc. NYSE:ELV | $92.84B | $429.69 | Undervalued | 16.3 | +24.51% |
Cigna Corporation NYSE:CI | $78.26B | $297.00 | Undervalued | 11.7 | -0.93% |
Centene Corporation NYSE:CNC | $35.28B | $71.27 | Undervalued | -4.7 | +74.74% |
Molina Healthcare, Inc. NYSE:MOH | $10.94B | $209.49 | Undervalued | 53.0 | +40.15% |
Clover Health Investments, Corp. NASDAQ:CLOV | $2.63B | $4.96 | Overvalued | -45.6 | +63.60% |
Alignment Healthcare, Inc. NASDAQ:ALHC | $1.54B | $7.36 | Undervalued | 227.0 | -61.86% |
Continue the stock analysis
Jump to another research area for this company.